[Damage control surgery for acute mesenteric ischemia]

Jian-Feng Gong1, Wei-Ming Zhu, Xing-Jiang Wu

  • 1Department of General Surgery, Jinling Hospital, Nanjing 200000, China.

Abstract

Insights

Damage control surgery (DCS) significantly improves survival rates for acute mesenteric ischemia (AMI) patients. Early thrombectomy and thrombolysis are crucial for managing AMI and preventing thrombosis progression.

Area of Science:

  • Gastroenterology
  • Surgical Innovation
  • Vascular Surgery

Context:

  • Acute mesenteric ischemia (AMI) presents a critical surgical challenge with high mortality.
  • Damage control surgery (DCS) offers a staged approach for managing complex abdominal catastrophes.
  • This study evaluates DCS in a cohort of patients with acute mesenteric ischemia.

Purpose:

  • To assess the efficacy and outcomes of damage control surgery (DCS) in patients diagnosed with acute mesenteric ischemia (AMI).
  • To analyze the impact of thrombectomy and thrombolysis within the DCS framework for AMI.
  • To determine survival rates and identify factors influencing outcomes in AMI patients undergoing DCS.

Summary:

  • A retrospective analysis of 15 acute mesenteric ischemia (AMI) patients treated with damage control surgery (DCS) was conducted.
  • The staged DCS approach involved bowel resection, thrombectomy, ICU resuscitation, and thrombolysis before definitive reconstruction.
  • Survival rate was 66.7% (10 out of 15), with no parenteral nutrition dependence among survivors. Key interventions included thrombectomy and thrombolysis.

Impact:

  • Damage control surgery (DCS) demonstrates a positive impact on survival for acute mesenteric ischemia (AMI) patients.
  • The findings underscore the importance of thrombectomy and thrombolysis in preventing disease progression.
  • This approach offers a viable strategy for managing severe AMI, potentially improving patient outcomes.

Related Concept Videos